Roadzen, Inc. (NASDAQ:RDZN – Get Free Report) was the target of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 396,200 shares, a decrease of 13.1% from the August 31st total of 456,100 shares. Based on an average daily trading volume, of 2,060,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 2.2% of the shares of the stock are short sold.
Roadzen Stock Performance
RDZN opened at $1.27 on Friday. Roadzen has a twelve month low of $1.20 and a twelve month high of $7.17. The firm’s 50-day moving average price is $1.59 and its 200 day moving average price is $3.18.
Roadzen (NASDAQ:RDZN – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($0.46) earnings per share (EPS) for the quarter. Roadzen had a negative net margin of 287.82% and a negative return on equity of 31,166.20%. The company had revenue of $8.93 million during the quarter.
Institutional Trading of Roadzen
Roadzen Company Profile
Roadzen, Inc, an insurtech company, provides various insurance products in the United States and internationally. It offers insurance as a service platform, including Via, which enables fleets, carmakers, and insurers to inspect a vehicle using computer vision; Global Distribution Network that enables the configuration, customer quote, payment, and administration of any insurance policy with any insurance carrier as the underwriter; xClaim, which enables digital, touchless, and real-time resolution of claims; StrandD, a digital, real-time dispatch, and tracking for roadside assistance and first notice of loss during accident claims; Good Driving that enables insurers and fleets to recognize drivers, train drivers, and build usage based insurance programs; and Drivebuddy AI, which provides driver-assistance capabilities.
Featured Stories
- Five stocks we like better than Roadzen
- 3 Monster Growth Stocks to Buy Now
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Stock Sentiment Analysis: How it Works
- MarketBeat Week in Review – 9/23 – 9/27
- What Are Growth Stocks and Investing in Them
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Roadzen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roadzen and related companies with MarketBeat.com's FREE daily email newsletter.